Lincoln National Corp’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,955
Closed -$285K – 940
2022
Q1
$285K Buy
3,955
+1,184
+43% +$85.3K 0.01% 728
2021
Q4
$254K Sell
2,771
-4
-0.1% -$478 0.01% 769
2021
Q3
$352K Sell
2,775
-156
-5% -$22.7K 0.01% 620
2021
Q2
$487K Sell
2,931
-2,356
-45% -$382K 0.01% 505
2021
Q1
$961K Buy
5,287
+419
+9% +$97.2K 0.02% 307
2020
Q4
$973K Buy
4,868
+2,223
+84% +$452K 0.03% 287
2020
Q3
$580K Buy
2,645
+1,490
+129% +$316K 0.02% 352
2020
Q2
$220K Sell
1,155
-445
-28% -$78K 0.01% 580
2020
Q1
$248K Buy
+1,600
New +$186K 0.01% 488

Other funds holding TDOC

Lincoln National Corp's TDOC Position: Q2 2022 in Review

Lincoln National Corp sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,955 shares — an estimated $285K sold.

Lincoln National Corp first reported a position in TDOC in Q1 2020 and held it in 9 quarters. The position peaked at $973K in Q4 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Lincoln National Corp reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Lincoln National Corp sold 3,955 Teladoc Health shares in Q2 2022, an estimated $285K.
  • Lincoln National Corp first reported a position in Teladoc Health in Q1 2020 and held it in 9 quarters.
  • Lincoln National Corp's Teladoc Health position peaked at $973K in Q4 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Lincoln National Corp's 13F filing for Q2 2022, filed 2 Aug 2022.